98%
921
2 minutes
20
The , , and genes encode for the nuclear MRN protein complex, which senses the DNA double strand breaks and initiates the DNA repair. The MRN complex also participates in the activation of ATM kinase, which coordinates DNA repair with the p53-dependent cell cycle checkpoint arrest. Carriers of homozygous germline pathogenic variants in the MRN complex genes or compound heterozygotes develop phenotypically distinct rare autosomal recessive syndromes characterized by chromosomal instability and neurological symptoms. Heterozygous germline alterations in the MRN complex genes have been associated with a poorly-specified predisposition to various cancer types. Somatic alterations in the MRN complex genes may represent valuable predictive and prognostic biomarkers in cancer patients. MRN complex genes have been targeted in several next-generation sequencing panels for cancer and neurological disorders, but interpretation of the identified alterations is challenging due to the complexity of MRN complex function in the DNA damage response. In this review, we outline the structural characteristics of the MRE11, RAD50 and NBN proteins, the assembly and functions of the MRN complex from the perspective of clinical interpretation of germline and somatic alterations in the , and genes.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051278 | PMC |
http://dx.doi.org/10.3390/ijms24065612 | DOI Listing |
Europace
August 2025
Hospital Universitario La Paz, IdiPaz, Madrid, Spain.
The 2024 European Heart Rhythm Association (EHRA) Summit in Warsaw focused on the digital transformation of arrhythmia management, convening over 130 stakeholders from academia, industry, and policy. This review summarises the current state (in 2025) and future directions of digital health in arrhythmia care, including remote monitoring (RM) of cardiac implantable electronic devices (CIEDs), mobile health (mHealth), artificial intelligence (AI), and integration into the European Health Data Space (EHDS). RM has become central to CIED follow-up, improving outcomes and reducing healthcare use.
View Article and Find Full Text PDFbioRxiv
July 2025
Department of Human Genetics, University of Michigan Medical School, Ann Arbor, MI, USA.
The MRE11 DNA nuclease plays central roles in the repair of DNA double-strand breaks (DSBs) as a core component of the heterotrimeric MRE11/RAD50/NBS1 (MRN) complex. MRN localizes to chromosomal DSBs and recruits and activates the apical DSB repair protein kinase, ATM, which phosphorylates downstream substrates to elicit cellular DNA damage responses. Pathogenic variants in cause the genome instability disorder ataxia-telangiectasia-like disorder (ATLD).
View Article and Find Full Text PDFActa Crystallogr F Struct Biol Commun
September 2025
Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, MN 55455, USA.
The MRE11-RAD50-NBS1/Xrs2 (MRN/X) protein complex acts as a first responder in DNA double-strand break repair and telomere-length maintenance, yet the structural architecture of the yeast ortholog Xrs2 has remained unresolved. In this study, we present the first structure of the folded N-terminal region of Xrs2 from Saccharomyces cerevisiae, resolved at 2.38 Å using X-ray crystallography.
View Article and Find Full Text PDFBiochem Biophys Res Commun
September 2025
Department of Biophysics, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India, 160012. Electronic address:
Dysregulation of DNA damage repair pathways and miRNA-mediated control play crucial targets in breast cancer therapeutics, highlighting the need for novel multi-targeted therapeutic agents. In this study, the druggability properties and biological activity of structurally distinct phytochemicals, Flavonoids (F), and Nitrogen-containing heterocyclic-compounds (N) on the DNA repair checkpoint sensor genes (MRN complex), miR-2909 expression, ROS, and cell cycle analysis in breast cancer cell models (MDA-MB-231 and MCF-7) were investigated and compared against the FDA-approved anticancer agent Palbociclib (P). Both compound classes significantly inhibited breast cancer cell proliferation, with nitrogen-containing heterocyclics showing superior cytotoxicity.
View Article and Find Full Text PDFPak J Med Sci
July 2025
Bakhtawar Kamal Resident Medical Officer, Department of Histopathology, Hayatabad Medical Complex, Peshawar, Pakistan.
Objective: To evaluate the adequacy of demographic, clinical, and specimen-related information provided to the histopathology laboratory.
Method: Total 400 biopsy requisition forms were studied retrospectively for the presence and absence of 20 different variables. This cross-sectional and single-centric study was conducted in a tertiary care setting in Peshawar Pakistan in year 2024.